IDEAYA Biosciences, Inc.
IDYA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001676725
In the last 90 days, IDEAYA Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 285 institutions reported holding it in 13F filings for Q2 2026, worth $3.80B in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in IDEAYA Biosciences, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 128
- +11 vs. Q4 2022
- Shares held
- 45.6M
- −381.7K (−0.8%) vs. Q4 2022
- Total value
- $625.4M
- −$209.6M (−25.1%) vs. Q4 2022
- New holders
- 22
- 54 more added
- Sold out
- 11
- 30 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IDYA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 285 | $3.80B |
| Q1 2026 | 254 | $3.16B |
| Q4 2025 | 246 | $3.32B |
| Q3 2025 | 224 | $2.56B |
| Q2 2025 | 204 | $2.04B |
| Q1 2025 | 207 | $1.54B |
| Q4 2024 | 206 | $2.36B |
| Q3 2024 | 209 | $2.91B |
| Q2 2024 | 199 | $2.90B |
| Q1 2024 | 204 | $3.47B |
| Q4 2023 | 157 | $2.35B |
| Q3 2023 | 144 | $1.61B |
| Q2 2023 | 138 | $1.33B |
| Q1 2023 | 128 | $625.4M |
| Q4 2022 | 117 | $835.0M |
| Q3 2022 | 112 | $667.1M |
| Q2 2022 | 96 | $489.0M |
| Q1 2022 | 103 | $392.9M |
| Q4 2021 | 110 | $820.7M |
| Q3 2021 | 91 | $837.9M |
| Q2 2021 | 84 | $533.4M |
| Q1 2021 | 89 | $558.6M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding IDEAYA Biosciences, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Two Sigma Investments, LP | 324,410 | $4.45M | 0.01% | +184,447+131.8% | Added |
| AXA S.A. | 340,216 | $4.67M | 0.02% | −753−0.2% | Reduced |
| Opaleye Management Inc. | 343,000 | $4.71M | 1.41% | +204,200+147.1% | Added |
| Cormorant Asset Management, LP | 350,000 | $4.81M | 0.32% | 00.0% | Unchanged |
| Northern Trust Corp | 404,503 | $5.55M | 0.00% | +1740.0% | Added |
| Ameriprise Financial Inc | 433,682 | $5.95M | 0.00% | +23,112+5.6% | Added |
| Sofinnova Investments, Inc. | 453,149 | $6.22M | 0.42% | −21,381−4.5% | Reduced |
| DAFNA Capital Management LLC | 468,358 | $6.43M | 1.93% | 00.0% | Unchanged |
| FMR LLC | 581,519 | $7.98M | 0.00% | +24,369+4.4% | Added |
| Janus Henderson Group PLC | 657,897 | $9.05M | 0.01% | −26,080−3.8% | Reduced |
| Baker Bros. Advisors LP | 832,769 | $11.4M | 0.06% | −835,586−50.1% | Reduced |
| Platinum Investment Management Ltd | 835,521 | $11.5M | 0.40% | +4,984+0.6% | Added |
| Geode Capital Management, LLC | 859,934 | $11.8M | 0.00% | +54,033+6.7% | Added |
| 5AM Venture Management, LLC | 868,520 | $11.9M | 3.05% | −327,778−27.4% | Reduced |
| Citadel Advisors LLC | 1,011,116 | $13.9M | 0.02% | +124,257+14.0% | Added |
| Dimensional Fund Advisors LP | 1,036,451 | $14.2M | 0.00% | +309,135+42.5% | Added |
| Price T Rowe Associates Inc | 1,466,587 | $20.1M | 0.00% | −196,941−11.8% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 1,743,628 | $23.9M | 0.53% | 00.0% | Unchanged |
| State Street Corp | 2,114,317 | $29.0M | 0.00% | −208,324−9.0% | Reduced |
| Boxer Capital, LLC | 2,202,812 | $30.2M | 1.49% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,320,998 | $31.9M | 0.00% | +31,196+1.4% | Added |
| BVF Inc | 2,455,089 | $33.7M | 1.23% | +250,000+11.3% | Added |
| Canaan Partners X LLC | 2,660,713 | $36.5M | 65.16% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 2,676,559 | $36.7M | 0.08% | +475,000+21.6% | Added |
| Federated Hermes, Inc. | 2,864,607 | $39.3M | 0.10% | +1070.0% | Added |
| BlackRock Inc. | 3,549,093 | $48.7M | 0.00% | +12,363+0.3% | Added |
| Logos Global Management LP | 3,600,000 | $49.4M | 7.07% | −300,000−7.7% | Reduced |
| Avidity Partners Management LP | 3,673,400 | $50.4M | 1.67% | −151,400−4.0% | Reduced |
| Tekla Capital Management LLC | 0 | $0 | 0.00% | −133,185−100.0% | Sold out |
| Ghisallo Capital Management LLC | 0 | $0 | 0.00% | −87,500−100.0% | Sold out |
| Nordea Investment Management AB | 0 | $0 | 0.00% | −62,325−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −32,072−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −14,502−100.0% | Sold out |
| Gyon Technologies Capital Management, LP | 0 | $0 | 0.00% | −8,721−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −3,792−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −3,502−100.0% | Sold out |
| High Net Worth Advisory Group LLC | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −1,251−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −250−100.0% | Sold out |